5.2 Enablement Requirement & Wands Factors

5.2 Enablement Requirement & Wands Factors

Under 35 U.S.C. § 112(a), the specification must describe the invention in such full, clear, concise, and exact terms as to enable any person skilled in the art to which it pertains to make and use the claimed invention.

MPEP § 2164 core standard: The threshold test for enablement is whether the specification discloses sufficient information to enable a person ordinarily skilled in the art (POSITA) to make and use the claimed invention without undue experimentation.

---

The Undue Experimentation Standard & In re Wands

The law does not prohibit all experimentation. Routine experimentation, standard optimization, or conventional testing to practice the invention is fully permissible. Enablement is violated only when the required experimentation is undue.

In the landmark case In re Wands, 858 F.2d 731 (Fed. Cir. 1988), the Federal Circuit established eight factors (the Wands Factors) that examiners and courts must balance when determining whether experimentation would be undue:

The 8 Wands Factors (MPEP § 2164.01(a))

1. Quantity of experimentation necessary: The time, effort, and resources required to practice the invention.
2. Amount of direction or guidance presented: The explicit instructions, protocols, and guidance in the specification.
3. Presence or absence of working examples: The inclusion of concrete, executed experimental protocols.
4. Nature of the invention: The technical complexity and scope of the subject matter.
5. State of the prior art: The level of knowledge, techniques, and public information available to POSITA.
6. Relative skill of those in the art: The education, training, and experience typical of practitioners in the field.
7. Predictability or unpredictability of the art: The certainty with which results can be extrapolated.
8. Breadth of the claims: The scope of coverage sought relative to the specific embodiments disclosed.

Important Supreme Court Note (Amgen Inc. v. Sanofi, 598 U.S. 594 (2023)): The Supreme Court unanimously reaffirmed the enablement requirement, holding that when claims are drawn to an entire broad class of antibodies defined functionally, the specification must enable the entire class. If making and using the full scope requires POSITA to engage in painstaking trial-and-error discovery across millions of candidate compounds, the claim is invalid for lack of enablement.

---

Working Examples vs. Prophetic (Paper) Examples

Patent applications frequently contain experimental examples to illustrate how to practice the invention. MPEP § 608.01(p) distinguishes between two types of examples:

Comparison of Example Types

Prophetic examples are entirely legitimate in U.S. patent practice. An applicant is not required to build a physical prototype or perform physical laboratory testing before filing a patent application (constructive reduction to practice). However, if prophetic examples are written in the past tense to mislead the examiner into believing real tests were performed, the application risks rejection or invalidation for fraud/inequitable conduct under 37 CFR 1.56.

---

Biological Deposit Requirements (MPEP Chapter 2400 & Budapest Treaty)

In certain biological, microbiological, and biotechnological inventions (such as novel hybridomas, specific bacterial strains, or unique cell lines), words and chemical structures alone are insufficient to enable a POSITA to make and use the invention.

To overcome this limitation, the USPTO established biological deposit procedures under 37 CFR 1.801 - 1.809 and MPEP Chapter 2400, implementing the international Budapest Treaty on the International Recognition of the Deposit of Microorganisms for the Purposes of Patent Procedure.

Key Rules for Biological Deposits

1. When Required: A deposit is mandatory if the biological material is essential to practice the invention, is not known and readily available to the public, and cannot be described in writing without undue experimentation.
2. Approved Depositories: The deposit must be made in an International Depositary Authority (IDA) recognized under the Budapest Treaty (such as the American Type Culture Collection / ATCC).
3. Timing of Deposit:
   • The physical deposit must be made on or before the filing date of the application, OR
   • During pendency, provided the deposit is completed no later than the date of payment of the Issue Fee under 37 CFR 1.804.
4. Term of Deposit: The deposit must be maintained for at least 30 years from the deposit date AND at least 5 years after the most recent request for a sample, whichever is longer.
5. Public Access: The depositor must agree that all restrictions on public access to the deposit will be irrevocably removed upon the grant of the patent.